Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |